News

Aurobindo Pharma‘s Famciclovir tablets 125mg, 250mg and 500mg are the generic version of Novartis Pharmaceuticals’ Famvir tablets 125mg, 250mg and 500mg and is indicated for the treatment of

Upon closing, PharmaSwiss is expected to have approximately EUR38m cash on hand and no debt. Following the acquisition, the senior management team of PharmaSwiss will remain with Valeant

The first, a Phase 2a study, will evaluate VB-111 in patients with advanced differentiated thyroid cancer (DTC), while the second trial, a Phase 1/2 trial, will evaluate VB-111

The randomised, double-blind, placebo-controlled, dose escalation study will be conducted at one centre in the US and is designed to enroll 65 subjects in eight dose cohorts. The

Prior to Nuvilex, Ryan worked as the CEO of RFR Consulting where he focused on helping businesses in the biotech industry through providing information, grant writing, business management,

Nuedexta is a combination of two components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling

In previous studies, Bavituximab when administered as monotherapy, demonstrated positive results on therapy antiviral activity of up to 1.5 log viral load reduction. The primary endpoints of the

According to the company, the vaccines have demonstrated safety and efficacy in study with animal models. Sinovac has developed the PPV and will retain full commercialization rights to

For the third quarter of 2010, the company posted a net income of $155m, compared to $326m for the same period in 2009. McKesson’s operating income for the